Skip to main content
. Author manuscript; available in PMC: 2010 Aug 5.
Published in final edited form as: Cancer. 2010 Jan 1;116(1):106–114. doi: 10.1002/cncr.24714

Table 6.

Median Response Duration in Responders and Subgroups*

Patient Group No. of Responders Duration of Response (95% CI), mo
Overall 75 9.2 (7.1-10.8)
Chemosensitive 45 10.0 (8.4-11.7)
Chemorefractory 23 6.3 (4.9-NA)
Alkylator sensitive 44 9.7 (8.3-11.7)
Alkylator refractory 18 7.7 (4.9 to NA)

95% CI indicates 95% confidence interval; NA, not available.

*

Subgroups do not total 75 patients, because some patients could not be characterized as sensitive versus refractory.